🕵 Peek into Buffett's portfolio to find hidden gems with new 13F filingsAsk WarrenAI

Advent Technologies Approves 1-for-30 Reverse Stock Split

Published 2024-05-01, 09:17 a/m

Advent Technologies Holdings, Inc. (Nasdaq: ADN) (“Advent” or the “Company”) announced today that it will move forward with a 1-for-30 reverse stock split of its issued and outstanding common stock. The Company expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market (“Nasdaq”) with the opening of trading at a date to be determined by the Company’s Board of Directors.

The reverse stock split was approved on April 30, 2024 by Advent’s Board of Directors, following approval by the Company's stockholders at a special meeting held on April 29, 2024. The reverse stock split is intended to bring Advent into compliance with Nasdaq's $1.00 per share minimum bid price requirement for continued listing and to make the Company's stock more attractive to a broader range of institutional and other investors. Additionally, on April 30, 2024, the Company submitted to Nasdaq its proposed compliance plan to file its Annual Report on Form 10-K on or before May 31, 2024.

Advent’s common stock and publicly traded warrants will continue to trade on the Nasdaq Capital Market under the symbols “ADN” and “ADNWW,” respectively, following the reverse stock split, with new CUSIP numbers. After the reverse stock split, the number of outstanding shares of common stock will be reduced from approximately 77.6 million to approximately 2.6 million, subject to adjustment for fractional shares. No fractional shares will be issued in connection with the split, and stockholders who would otherwise be entitled to a fractional share will receive a proportional cash payment. Proportional adjustments will be made to the number of shares of common stock issuable upon conversion or exercise of the Company's equity awards and warrants, as well as the applicable conversion or exercise price.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.

Advent’s transfer agent, Continental Stock Transfer & Trust Company, will act as the exchange agent for the reverse stock split and will provide instructions to stockholders regarding the process. Additional information concerning the reverse stock split can be found in Advent’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on March 29, 2024.

Is ADN truely undervalued?

With ADN making headlines, investors are asking: Is it truly valued fairly? InvestingPro's advanced AI algorithms have analyzed ADN alongside thousands of other stocks to uncover hidden gems with massive upside. And guess what? ADN wasn't at the top of the list.

Unlock ProPicks AI

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.